DB
ATHE

Danske Bank’s Alterity Therapeutics ATHE Stock Holding History

Danske Bank’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4 Hold
1
– – ﹤0.01% 1112
2025
Q4 		$3 Hold
1
– – ﹤0.01% 1521
2025
Q3 		$4 Hold
1
– – ﹤0.01% 1443
2025
Q2 		$4 Hold
1
– – ﹤0.01% 1481
2025
Q1 		$3 Hold
1
– – ﹤0.01% 1332
2024
Q4 		$3 Hold
1
– – ﹤0.01% 1364
2024
Q3 		$1 Buy
+1
New +$1 ﹤0.01% 1583

Other funds holding ATHE

TLCM
Twin Lakes Capital Management Redwood Shores, California $220M AUM 31.75% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $15.5B AUM 18.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GT
Greenleaf Trust Kalamazoo, Michigan $10.2B AUM 2.09% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Danske Bank's ATHE Position: Q1 2026 in Review

Danske Bank held its Alterity Therapeutics (ATHE) position steady in Q1 2026 at 1 share worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #1112.

Danske Bank first reported a position in ATHE in Q3 2024 and has held it in 7 quarters since. 15 funds tracked by Wall St. Rank hold ATHE as of Q1 2026.

  • Danske Bank held 1 share of Alterity Therapeutics worth $4 as of Q1 2026.
  • Danske Bank left its Alterity Therapeutics share count unchanged in Q1 2026.
  • Alterity Therapeutics made up ﹤0.01% of Danske Bank's portfolio in Q1 2026, its #1112 holding.
  • Danske Bank first reported a position in Alterity Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • 15 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.